In conclusion, COPD is a global disease, with increasing prevalence and health-related impact. The loss of FEV 1 may be slowing down, but what is really needed is an intervention that improves it in ...

The final session of the symposium, "Impact on Chest Wall and Respiratory Muscles," was presented by Professor Peter T. Macklem, of the Meakins-Christie Labs at McGill University Health Center in ...

Paraseptal emphysema (PSE) is a type of pulmonary emphysema. In PSE, the outermost parts of the lungs fill with enlarged air spaces. This can cause breathing difficulties and other respiratory ...

Lung cancer is among the most common cancers worldwide. In the United States and other industrialized countries, it’s the major cause of cancer mortality. Emphysema is a term that describes structural ...

Obstructive pulmonary disease is a collective term for refractory respiratory diseases with chronic airway inflammation and excessive mucus retention that are accompanied by airway obstruction. They ...

Elevated sputum azurocidin-1 levels correlate with worsening lung function and increased exacerbation frequency in patients with bronchiectasis.

Pegtarazimod holds promise for effectively treating acute exacerbations of COPD, a major unmet need in COPD treatment.

Early signs of emphysema may be subtle, including shortness of breath during physical activity, a mild cough, and slight fatigue, so it’s important to pay attention to any changes in your breathing or ...

With emphysema, you can have symptoms like shortness of breath, coughing, wheezing, and chest tightness. Your symptoms can ...